Consider the major pharmacokinetic changes that occur during development and aging when new-generation antiepileptic drugs are prescribed at the extremes of age

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.2, 2007-02, pp. : 24-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of New-Generation Antiepileptic Drugs at the Extremes of Age

By Perucca Emilio  

Clinical Pharmacokinetics, Vol. 45, Iss. 4, 2006-01 ,pp. : 351-363

Adis International

Access to resources Recommend Favorite

The new generation of anti-epileptic drugs

By Patsalos P.N.  

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 87-106

Informa Healthcare

Access to resources Recommend Favorite

Consider possible changes in the pharmacokinetic properties of antibacterials when treating the critically ill

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 9, 2006-09 ,pp. : 21-23

Adis International

Access to resources Recommend Favorite

Pros and Cons for the Development of New Antiepileptic Drugs

By Bialer M.  

CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. : 285-289

Adis International

Access to resources Recommend Favorite

Recent trends in the development of new anti-epileptic drugs

By Wolfe J.F.   Greenwood T.D.   Mulheron J.M.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 361-381

Informa Healthcare

Access to resources Recommend Favorite